1-13 of 13
Vladimir Jankovic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Circulating Tumor DNA Analysis Associates with Progression-Free Survival (PFS) with Odronextamab Monotherapy in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Identification of Minimal Residual Disease Status and High-Risk Subgroups from the Phase 2 ELM-2 Study

Jon E. Arnason, Jurriaan Brouwer-Visser, Stefano Luminari, David Tucker, Tae Min Kim, Won Seog Kim, Laura Magnano, Dylan Sun, Jessica Cai, Kamil Cygan, Srikanth Ambati, Hesham Mohamed, Aafia Chaudhry, Vladimir Jankovic
Journal: Blood
Blood (2023) 142 (Supplement 1): 427.
https://doi.org/10.1182/blood-2023-179812
Published: 2023
Journal Articles

Optimization of Intravenous Odronextamab Step-up Regimen for Reducing the Risk of High-Grade Cytokine Release Syndrome

Min Zhu, Jurriaan Brouwer-Visser, Srikanth R. Ambati, Hesham Mohamed, Vladimir Jankovic, Fang Wang, Hong Yan, Jingxian Cai, Carolina Leite De Oliveira, Melanie Ufkin, John D. Davis, Aafia Chaudhry, Masood Khaksar Toroghi
Journal: Blood
Blood (2022) 140 (Supplement 1): 11560–11561.
https://doi.org/10.1182/blood-2022-158415
Published: 2022
Journal Articles

Baseline Biomarkers of T-Cell Function Correlate with Clinical Responses to Odronextamab (REGN1979), and Loss of CD20 Target Antigen Expression Identified As a Mechanism of Treatment Resistance

Jurriaan Brouwer-Visser, PhD, Nathalie Fiaschi, PhD, Raquel P. Deering, PhD, Ankur Dhanik, PhD, Kamil J. Cygan, PhD, Wen Zhang, PhD, Se Jeong, MPH, Stephane Pourpe, MS, Lauren Boucher, Sara Hamon, PhD, Max S. Topp, MD, Rajat Bannerji, MDPhD, Johannes Duell, MD, Ranjana Advani, MD, Dina M. Flink, PhD, Aafia Chaudhry, MD MBA, MS, Andres Sirulnik, MD PhD, Andrew J. Murphy, PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Gavin Thurston, PhD, Srikanth R. Ambati, MBBS, MD, Vladimir Jankovic, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-137499
Published: 2020
Journal Articles

A Phase 2 Study of Odronextamab (REGN1979), a CD20 x CD3 Bispecific Antibody, in Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Tae Min Kim, MD PhD, Arancha Alonso, MD, Miles Prince, MD, Michal Taszner, MD, Seok-Goo Cho, MD, PhD, Don A. Stevens, MD, Michelle Poon, MD, Francesca Lim, MBBS, BSc, MRCP (UK), Steven Le Gouill, MD PhD, Cecilia Carpio, MD, Mary-Margaret Keating, MD FRCPC, Lieve Adriaens, PharmD, Melanie Ufkin, PhD, Ayesha Sabir, BSc, Jingjin Li, PhD, Vladimir Jankovic, MD, Min Zhu, PhD, Jurriaan Brouwer-Visser, PhD, Siyang Leng, MD MS, L. Andres Sirulnik, MD PhD, Aafia Chaudhry, MD MBA, MS, Srikanth R. Ambati, MBBS, MD, Kim Won Seog, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 28–29.
https://doi.org/10.1182/blood-2020-136344
Published: 2020
Journal Articles

A Phase 2 Study of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody (Ab), in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)

Max S. Topp, MD, Johannes Duell, MD, Jingjin Li, PhD, Vladimir Jankovic, MD, Israel Lowy, MD PhD, David Sternberg, MD PhD, Lieve Adriaens, PharmD, Mary Peterman, PharmD, Srikanth R. Ambati, MBBS, MD, Rajat Bannerji, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4007.
https://doi.org/10.1182/blood-2019-126670
Published: 2019
Journal Articles

Clinical Activity of REGN1979, a Bispecific Human, Anti-CD20 x Anti-CD3 Antibody, in Patients with Relapsed/Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-NHL)

Rajat Bannerji, MD PhD, John N. Allan, MD, Jon E. Arnason, MD, Jennifer R. Brown, MD PhD, Ranjana H Advani, MD, Jeffrey A. Barnes, MD PhD, Stephen M Ansell, MD PhD, Susan M. O'Brien, MD, Julio Chavez, Johannes Duell, MD, Kevin A. David, MD, Peter Martin, FRCPC, MD MS, Robin M. Joyce, MD, Robert Charnas, PhD, Srikanth R. Ambati, MBBS, MD, Lieve Adriaens, PharmD, Melanie Ufkin, PhD, Min Zhu, PhD, Jingjin Li, PhD, Peter Gasparini, MS, Anfal Ibrahim, BS, Vladimir Jankovic, MD, Nathalie Fiaschi, PhD, Olulanu Aina, PhD, Wen Zhang, PhD, Raquel P. Deering, PhD, Sara Hamon, PhD, Gavin Thurston, PhD, Andrew J. Murphy, PhD, David M. Weinreich, MD, George D. Yancopoulos, MD PhD, Israel Lowy, MD PhD, David Sternberg, MD PhD, Max S. Topp, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 762.
https://doi.org/10.1182/blood-2019-122451
Published: 2019
Journal Articles

Emerging Clinical Activity of REGN1979, an Anti-CD20 x Anti-CD3 Bispecific Antibody, in Patients with Relapsed/Refractory Follicular Lymphoma (FL), Diffuse Large B-Cell Lymphoma (DLBCL), and Other B-Cell Non-Hodgkin Lymphoma (B-NHL) Subtypes

Rajat Bannerji, MDPhD, Jon E. Arnason, MD, Ranjana Advani, MD, Jennifer R. Brown, MD PhD, John N. Allan, MD, Stephen M. Ansell, MD PhD, Jeffrey Barnes, MD PhD, Susan M. O'Brien, MD, Julio C. Chavez, MD, Johannes Duell, MD, Israel Lowy, MD PhD, Robert Charnas, PhD, David Sternberg, MD PhD, Srikanth Ambati, MBBS, MD, Lieve Adriaens, PharmD, Melanie Ufkin, PhD, Xiaoyu Yan, PhD, Jingjin Li, PhD, Mark Navarro, BA, Peter Gasparini, MS, Vladimir Jankovic, MD, Nathalie Fiaschi, PhD, Wen Zhang, PhD, Sara Hamon, PhD, Gavin Thurston, PhD, Max S. Topp
Journal: Blood
Blood (2018) 132 (Supplement 1): 1690.
https://doi.org/10.1182/blood-2018-99-113328
Published: 2018
Journal Articles

Stroma-Free Ex Vivo Expanded, CD34+ Cord Blood-Derived NK Cells Retain Lytic Activity After Long-Term Engraftment in NSGS Mice

Mark Wunderlich, MS, Mahesh Shrestha, MS, Lin Kang, PhD, Eric Law, MS, Vladimir Jankovic, MD, Xiaokui Zhang, PhD, Uri Herzberg, PhD, DVM, Stewart Abbot, PhD, Robert Hariri, MD, PhD, James C. Mulloy, PhD
Journal: Blood
Blood (2012) 120 (21): 580.
https://doi.org/10.1182/blood.V120.21.580.580
Published: 2012
Journal Articles

Depletion of L3MBTL1, a PcG Gene Deleted in Patients with 20q-Associated with Hematologic Malignancies, Accelerates Erythroid Differentiation of Hematopoietic Progenitor Cells

Fabiana Perna, Nadia Gurvich, Ruben Hoya-Arias, Francesca Voza, Vladimir Jankovic, Nagesh Kalakonda, Stephen D. Nimer
Journal: Blood
Blood (2008) 112 (11): 3740.
https://doi.org/10.1182/blood.V112.11.3740.3740
Published: 2008
Journal Articles

Cyclin C Regulates the Quiescence of Human CD34+CD38- Hematopoietic Stem Cells.

Yasuhiko Miyata, Yan Liu, Vladimir Jankovic, Goro Sashida, Silvia Menendez, Shannon Elf, Anthony Deblasio, Stephen D. Nimer
Journal: Blood
Blood (2007) 110 (11): 1273.
https://doi.org/10.1182/blood.V110.11.1273.1273
Published: 2007
Journal Articles

Identification of Key Cellular Regulators That Interact with Id1 To Control Hematopoietic Stem Cell Behavior.

Vladimir Jankovic, MD, Alessia Ciarrocchi, PhD, Tony DeBlasio, Robert Benezra, PhD, Stephen D. Nimer, MD
Journal: Blood
Blood (2006) 108 (11): 1319.
https://doi.org/10.1182/blood.V108.11.1319.1319
Published: 2006
Journal Articles

The Deletion of NHR1 Region of the AML1-ETO Protein Significantly Decreases Its Ability To Promote Proliferation and Self-Renewal of Early Hematopoietic Cells in Culture.

Alexander Gural, MD, Vladimir Jankovic, MD, Jinsong Zhang, PhD, Robert G. Roeder, PhD, Stephen D. Nimer, MD
Journal: Blood
Blood (2006) 108 (11): 2550.
https://doi.org/10.1182/blood.V108.11.2550.2550
Published: 2006
Journal Articles

Id1 Regulates the Choice of Hematopoietic Stem Cells to Self-Renew or Commit to Differentiation.

Vladimir Jankovic, MD, Alessia Ciarrocchi, PhD, Piernicola Boccuni, MD, Robert Benezra, PhD, Stephen D. Nimer, MD
Journal: Blood
Blood (2005) 106 (11): 270.
https://doi.org/10.1182/blood.V106.11.270.270
Published: 2005